Grants
The Fundación Conchita Rábago has awarded two grants since it was founded in 1969.
One to train predoctoral researchers at the Fundación Jiménez Díaz .
The other provides assistance to doctors from the Jiménez Díaz Foundation, enabling them to broaden their education at other national and international centres so that the home institution can benefit from what they learn.
The Board of Trustees of the Conchita Rábago Foundation
CALL
Becas Predoctorales de Investigación “Jiménez Díaz” con arreglo a las siguientes normas:
1.- Las Becas tendrán una duración de un año, de enero a diciembre de 2024.
2.- Estarán dotadas de una asignación a determinar.
3.- Para disfrutar estas Becas será indispensable la dedicación plena a un proyecto de investigación financiado, adscrito a un investigador principal del IIS-FJD radicado en la Fundación Jiménez Díaz de Madrid. Dado que la presente convocatoria tiene una dimensión limitada, se dará prioridad a los investigadores de grupos de investigación emergentes.
4.- El plazo de presentación de solicitudes finalizará el día 10 de noviembre.
5.- La solicitud deberá ser remitida por correo postal a la Fundación Conchita Rábago de Jiménez Díaz (Calle Príncipe de Vergara 9, 5º Izda. 28001 Madrid). Asimismo, se deberá remitir una copia escaneada completa con firmas por correo electrónico a isabelferreiro@fundacionconchitarabago.net. Las solicitudes deben incluir la siguiente documentación:
1. Cover Letter containing the following information:
- Director of the scholarship (Name and surname, Position, Department, IIS-FJD Area).
- Scholarship candidate (Name and surname).
- Project (funded project, agency and effective date) and Title of the Grant project.
- The letter must be signed by the Scholarship Director and the Candidate.
2. Corresponding application form duly completed.
3. Updated CV.
4. Certificate of studies (only for new requests)
Candidates must have graduated within the last five years as of the year for which the call is requested.
6.- This Board of Trustees may request a report on the progress of the research at any time while enjoying the Scholarship. If this is not satisfactory, the Scholarship may be rescinded.
Fellows 2024
Fourth year
RODILLA HERNÁNDEZ, CRISTINA
Bachelor: Biochemistry
University: UAM - 2018
Master: Master in Health Analysis – 2018 - 2020
Group: Genetics and Genomics of Rare Diseases
IIS-FJD Area: Genetics and Genomics
Director: Dr. Carmen Ayuso/Dr. Marta Cortón
Group type: Consolidated
Project: Clinical and molecular characterization of retinal pathologies that cause blindness in children through genomic analysis and functional modeling.
1.- Funded project to which it belongs: Retinal dystrophies: a genomic, cellular, functional and bioinformatics approach, to accelerate their diagnosis and treatment, and measure their impact.
Agency and Reference: ISCIII – PI19/0321
Funded period: 2020-2022
2.- Funded project to which it is ascribed: Deciphering the ocular developmental disorders by integration of multi-omics data and experimental modeling to facilitate diagnosis and therapeutic opportunities.
Agency and Reference: ISCIII - PI20/00851
Funded period: 2021-2023
3. Funded project to which it is ascribed: A comprehensive study of hereditary retinal dystrophies: improvement of molecular diagnosis, therapeutic approaches, clinical trials and measurement of the impact on patients.
Agency and Reference: ISCIII - PI22/00321
Funded period: 2023-2025
Doctoral Thesis presentation expected date: December 2024
SOTO CATALÁN, MANUEL
Bachelor: Biochemistry
University: Castilla La Mancha 2017
Master: Master in Research, Development, Control and Innovation of Medicines 2017-2018
Group: Vascular Pathology
IIS-FJD Area: Kidney, Metabolic and Cardiovascular Diseases
Director: Dr. Jesús Egido (Director)
Group type: Consolidated
Project: Inflammation as a therapeutic target in the complications of type 2 diabetes
1.- Funded project to which it is ascribed: Targeting inflammation in type 2 diabetes complications
Agency and Reference: ISCIII –PI20/00487
Funded period: 2020-2023
2.- Funded project to which it is ascribed: The role of inflammation in the prevention of type 2 diabetes. The modulation of inflammatory signaling pathways as an added therapy to new antidiabetic drugs.
Agency and Reference: Carlos III Health Institute FIS PI23/00119.
Funded period: 2024-2026.
Doctoral Thesis presentation expected date: December 2024
First year
DE LA RIVA BUENO, MACARENA
Bachelor: Health Biology
University: University of Alcalá – 2023
Master (IN PROGRESS): Master of Research in Translational Medicine 2023/24
IIS-FJD Area: Infectious, Inflammatory and Chronic Diseases
Group: Rheumatology and Bone Metabolism
Director: Dr. Aranzazu Mediero Muñoz
Group type: Emerging
Project: Study of the comorbidity of non-alcoholic fatty liver in patients with rheumatoid arthritis and involvement of the purinergic system as therapy.
Funded project to which it is attached:
MODULATION OF THE PURINERGIC SYSTEM WITH AGENTS THAT INCREASE EXTRACELLULAR LEVELS
OF ADENOSINE AS POTENTIAL THERAPEUTIC TARGETS FOR SARCOPENIA.
Agency: ISCIII
Reference: PI22/00347
Funded period: 2023-2025
FRUTOS DÍAZ ALEJO, JESÚS
Bachelor: Health Biology
University: University of Alcalá - 2019
Master: Therapeutic targets in cell signaling: research and development - 2019/20
IIS-FJD Area: Cancer
Group: Pathological Anatomy. Lymphoma
Director: Dr. Socorro María Rodríguez Pinilla
Group type: Emerging
Project: Molecular characterization of Angioimmunoblastic T Lymphoma.
Funded project to which it is attached:
COMPREHENSIVE MOLECULAR STUDY OF TANGIOIMMUNOBLASTIC LYMPHOMA.
Agency: Carlos III Health Institute (ISCIII)
Reference: PI21/01724
Funded period: 2022-2024
LÓPEZ BLÁZQUEZ, CARLOS
Bachelor:Biology
University: Autonomous University of Madrid - 2022
Master: Molecular Biomedicine - 2022/23
IIS-FJD Area: Cancer
Group: Medical Oncology
Director: Dr. Javier Martínez Useros
Group type: Emerging
Project: Determination of molecular targets for the generation of new therapies (nanobodies) in pancreatic and colorectal cancer.
Funded project to which it is attached:
PLATFORM FOR ACCELERATED DISCOVERY ED NANOBODIES - ACCELERATED
DISCOVERY NANOBODY PLATFORM.
Agency: HORIZON-EIC-2023-PATHFINDEROPEN
Reference: PIC235-23
Funded period: 2024-2027
LÓPEZ LÓPEZ, LUCÍA
Double Bachelor: Pharmacy and Biotechnology
University: CEU San Pablo Madrid University – 2022
Master (IN PROGRESS): Master in Bioinformatics and Data Science in Personalized Precision Medicine and Health
2023/24
IIS-FJD Area: Genetics and Genomics
Group: Genetics and Genomics of Rare Diseases
Director: Dr. Berta Almoguera Castillo
Group type: Emerging
Project: Identification of mechanisms involved in the etiology and clinical presentation of neurodevelopmental disorders with genomic, epigenomic and transcriptomic approaches.
Funded project to which it is attached:
IDENTIFICATION OF MECHANISMS INVOLVED IN THE ETIOLOGY AND CLINICAL PRESENTATION OF NEURODEVELOPMENTAL DISORDERS WITH GENOMIC, EPIGENOMIC AND TRANSCRYPTOMIC APPROACHES.
Agency: ISCIII
Reference: PI23/00477
Funded period: 2024-2026 01/2024 – 12/2026
ROCHANO ORTIZ, ANTONIO
Bachelor: Biology
University: Complutense University of Madrid - 2022
Master: Molecular Biomedicine- 2022/23
IIS-FJD Area: Kidney, Metabolic and Cardiovascular Diseases
Group: Vascular and Renal Pathology. Cardiovascular Metabolism
Director: Dr. Jorge Oller Pedrosa
Group type: Emerging
Project: New molecular targets in vascular diseases and Marfan Syndrome
Funded project to which it is attached:
NEW METABOLIC THERAPEUTIC TARGETS IN AORTOPATHIES
Agency: Ministry of Science and Innovation
Reference: PID2022-137730OA-100
Funded period: 2023-2026
ROMERO COTE, MARÍA
Bachelor: Biology
University: University of Córdoba – 2019
Master: Master's Degree in Translational Biomedical Research 2019/20
IIS-FJD Area: Kidney, Metabolic and Cardiovascular Diseases
Group: Nephrology
Director: Dr. Emilio González Parra
Group type: Consolidated
Project: Impact of aromatic uremic toxins and bisphenols on oxidation and inflammation in patients with chronic kidney disease (CKD). Role in the progression of vascular and nutritional damage
Funded project to which it is attached:
IMPACT OF AROMATIC UREMIC TOXINS AND BISPHENOLS ON OXIDATION AND INFLAMMATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD). ROLE IN THE PROGRESSION OF VASCULAR AND NUTRITIONAL DAMAGE
Agency: ISCIII- Ministry of Science and Innovation
Reference: PI21/01430
Funded period: 2022-2024